What are the signs and symptoms of an epoprostenol (Flolan) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Epoprostenol (Flolan) Overdose Symptoms

Acute epoprostenol overdose primarily causes systemic hypotension, while chronic overdose leads to a hyperdynamic state and high-output cardiac failure. 1

Acute Overdose Manifestations

The signs and symptoms of acute epoprostenol overdose are extensions of its dose-limiting pharmacologic effects and include 1, 2:

  • Systemic hypotension (most clinically significant)
  • Flushing
  • Headache
  • Nausea and vomiting
  • Diarrhea

These acute effects are typically self-limiting and resolve with dose reduction or temporary withholding of the medication 2. In clinical trials, only two cases of overdose produced substantial hemodynamic concern (hypotension and near-syncope) 2.

Severe Acute Overdose Case

One documented pediatric case involved accidental administration of 7.5 mg via central venous catheter, resulting in 2:

  • Flushing
  • Headache
  • Nausea and vomiting
  • Hypotension
  • Seizure-like activity with loss of consciousness lasting several minutes
  • Complete recovery occurred

Chronic Overdose Manifestations

Long-term overdosage produces distinctly different pathophysiology, leading to 1:

  • Development of a hyperdynamic state
  • High-output cardiac failure

These chronic effects are dose-dependent and typically respond to cautious dose reduction 1.

Common Therapeutic Side Effects (Not Overdose)

It's important to distinguish overdose symptoms from common therapeutic side effects that occur at normal doses 1:

  • Headache
  • Flushing
  • Jaw pain with initial mastication
  • Diarrhea
  • Nausea
  • Blotchy erythematous rash
  • Musculoskeletal aches and pain (predominantly legs and feet)

Management Approach

Immediate dose reduction or temporary withholding is the primary intervention for suspected overdose 2. Most overdose events in clinical trials resulted from 2:

  • Accidental bolus administration
  • Errors in pump-programmed rate
  • Prescription of incorrect dose

Critical Distinction: Abrupt Discontinuation

While not overdose, abrupt interruption of epoprostenol carries potentially fatal consequences and must be distinguished from overdose scenarios. Sudden cessation can cause 1:

  • Rebound worsening of pulmonary hypertension
  • Symptomatic deterioration
  • Potential death within 20-30 minutes in severely dependent patients

This rebound phenomenon is the opposite of overdose toxicity and requires immediate reinitiation of therapy, not dose reduction.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.